You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 14, 2025

Bulk Pharmaceutical API Sources for TRIBENZOR


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for TRIBENZOR

Vendor Vendor Homepage Vendor Sku API Url
Starshine Chemical ⤷  Get Started Free 2023-05-10B0613 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: TRIBENZOR

Last updated: July 30, 2025


Introduction

TRIBENZOR, the commercial name for the combination of olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide, is a widely prescribed antihypertensive medication indicated for the management of hypertension. As a complex pharmaceutical formulation comprising multiple active ingredients, sourcing high-quality bulk APIs becomes crucial for manufacturers. This article provides a comprehensive overview of the principal suppliers and manufacturing sources for the individual APIs integral to TRIBENZOR, delving into their manufacturing capabilities, regulatory standing, and global footprint.

Understanding the API Composition of TRIBENZOR

TRIBENZOR's effectiveness hinges on the quality and supply stability of its constituent APIs, which include:

  • Olmesartan Medoxomil – an angiotensin II receptor blocker (ARB)
  • Amlodipine Besylate – a calcium channel blocker
  • Hydrochlorothiazide – a thiazide diuretic

Each API's sourcing involves a different set of manufacturers, often operating within rigorous quality frameworks meeting international standards such as cGMP (current Good Manufacturing Practice).


Major API Suppliers for Olmesartan Medoxomil

Global Manufacturing Landscape

Olmesartan medoxomil has seen significant production from established pharmaceutical API producers primarily in India, China, and Europe. The APIs must adhere to stringent quality standards to ensure safety and efficacy.

Leading Suppliers:

  • Hetero Labs (India)
    A prominent player in complex generics, Hetero supplies olmesartan medoxomil globally, leveraging extensive R&D and manufacturing facilities compliant with cGMP. Its API quality aligns with US FDA and EMA standards.

  • Mundipharma (Switzerland)
    Known for high-quality APIs, Mundipharma supplies olmesartan medoxomil with a focus on North American and European markets. Their facilities are registered with multiple regulatory bodies.

  • Zhejiang Huahai Pharmaceutical (China)
    As a leading Chinese API producer, Huahai offers competitively priced olmesartan medoxomil, with certifications verifying compliance with international standards.

  • Sun Pharmaceutical Industries (India)
    A key API manufacturer, Sun Pharma ensures supply stability for olmesartan medoxomil, meeting global GMP requirements.


Key Suppliers for Amlodipine Besylate

Manufacturers and Distributors

  • Granules India (India)
    A major API manufacturer known for high-quality amlodipine besylate, Granules India services global markets with APIs conforming to strict quality regulations.

  • Dr. Reddy’s Laboratories (India)
    Reddy’s supplies amlodipine besylate with demonstrated compliance to cGMP standards, supporting diverse formulations worldwide.

  • AstraZeneca (Licensed API manufacturing)
    Historically, AstraZeneca's APIs are produced in-house or through licensed third-party manufacturers complying with international standards for amlodipine.

  • Ming Fong Pharmaceutical (China)
    Provides bulk amlodipine besylate APIs for regional and global markets, with certifications including ISO and GMP.


Leading Sources for Hydrochlorothiazide

Market Leaders

  • Hetero Labs (India)
    Among the predominant suppliers of hydrochlorothiazide, Hetero offers API quality that adheres to global pharmaceutical standards.

  • Tianjin Phytoplankton Biological Technology (China)
    A key manufacturer supplying hydrochlorothiazide, with GMP certification and competitive pricing.

  • ATG Europe (Germany)
    Specializes in high-purity hydrochlorothiazide APIs with a focus on European regulatory compliance.

  • Glenmark Pharmaceuticals (India)
    A reputable API producer, offering hydrochlorothiazide manufactured under cGMP conditions.


Regulatory Considerations and Quality Assurance

Sourcing APIs for TRIBENZOR requires rigorous adherence to regulatory standards, including certifications from agencies like the U.S. FDA, EMA, and WHO. Many suppliers maintain cGMP certifications and undergo frequent audits to ensure compliance, critical for global distribution.

Additionally, stability studies, impurity profiles, and bioavailability data help determine the suitability of suppliers' APIs for licensed pharmaceuticals. Suppliers often provide Certificates of Analysis (CoA), stability data, and batch documentation to support quality assurance.


Supply Chain and Global Distribution Dynamics

The global API industry faces challenges such as geopolitical disruptions, supply chain bottlenecks, and regulatory shifts. Many manufacturers diversify sourcing to mitigate risks, emphasizing supply chain resilience. Indian companies like Hetero, Sun Pharma, and Granules India dominate the API market for TRIBENZOR components, supported by aging Chinese manufacturing infrastructure transforming to meet evolving standards.

Manufacturers seeking OEM (Original Equipment Manufacturer) partnerships should prioritize suppliers with proven quality records, scalable production capabilities, and reliable logistics. Contract manufacturing organizations (CMOs) often act as intermediaries, providing access to vetted API sources.


Innovations and Future Trends

The API industry is witnessing significant innovation aimed at improving sustainability, reducing impurity levels, and enhancing bioavailability profiles. Technologies such as continuous manufacturing, green chemistry, and advanced purification techniques are increasingly adopted by top suppliers to meet evolving regulatory standards and environmental considerations.

Moreover, the shift toward biologics and complex small molecules implies future API markets will prioritize quality, traceability, and seamless regulatory pathways.


Conclusion

For TRIBENZOR production, sourcing high-quality APIs relies on engaging with reputable manufacturers that meet international GMP standards. Companies like Hetero Labs, Granules India, and Tianjin Phytoplankton stand out as dependable sources for olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide, respectively. Ensuring supply stability, regulatory compliance, and product quality remains paramount as global supply chains evolve.


Key Takeaways

  • Prioritize supplier quality certifications: Ensure APIs are produced by manufacturers with GMP certifications supporting global regulatory approval.
  • Diversify sourcing strategies: Engage multiple reputable suppliers to mitigate supply chain risks.
  • Monitor regulatory compliance: Regular audits and up-to-date documentation support uninterrupted supply and quality assurance.
  • Leverage emerging innovations: Embrace new manufacturing technologies to improve sustainability, efficiency, and drug purity.
  • Maintain supply chain transparency: Traceability and documentation fortify compliance, reducing regulatory liabilities.

FAQs

Q1: Which regions dominate the API manufacturing landscape for TRIBENZOR components?
A1: India and China are primary regions, with leading manufacturers such as Hetero, Sun Pharma, Granules India, and Zhejiang Huahai, supported by European players like AstraZeneca and ATG Europe.

Q2: What regulatory certifications should suppliers of TRIBENZOR APIs possess?
A2: Suppliers should ideally have cGMP certifications aligned with the FDA, EMA, or WHO standards, ensuring quality, safety, and efficacy.

Q3: How does supply chain stability impact TRIBENZOR manufacturing?
A3: Reliable API supply chains prevent production delays, ensure consistent product quality, and support regulatory compliance—vital factors for global market access.

Q4: Are there sustainability considerations when sourcing APIs for TRIBENZOR?
A4: Yes. Focus is shifting towards environmentally sustainable manufacturing practices, such as green chemistry and waste reduction, by leading API producers.

Q5: How can manufacturers verify the quality of APIs before sourcing?
A5: By reviewing Certificates of Analysis, batch records, stability data, and conducting audits or audits via third-party regulatory agencies.


References:

[1] U.S. Food and Drug Administration (FDA). “Guidance for Industry: API Manufacturing.”

[2] World Health Organization (WHO). “Prequalification of Medicines Programme.”

[3] Hetero Labs Ltd. Company website. “API Portfolio and GMP Certifications.”

[4] Granules India Ltd. Public disclosures on API production standards and certifications.

[5] Zhejiang Huahai Pharmaceutical. Regulatory filings and quality certifications.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.